HKU start-up wins top prize at Inaugural Hello Tomorrow Singapore Regional Summit
30 Dec 2018Back to News & Successful Stories
Lifespans, a start-up company formed by HKU professors and alumni, won top prize at the Inaugural Hello Tomorrow Singapore Regional Summit. The team uses advanced materials to tackle complications stemming from orthopaedic implants within the growing elderly population.
The start-up company invents, manufactures, and sells innovative trauma and spine implants optimised for repairing common bone fractures such as the hip, shoulder and spine, At present, the rigid, all-metal implants on the market easily break through elderly bone, failing after surgery at rates as high as 25-35%. Lifespans takes the design approach of “soft implants for soft bones” - that is, using soft polymer materials and mechanical features that are gentle yet firm when repairing fractures in elderly patients.
Ten of the best deep-tech start-ups, selected from over 200 applications in the region from companies discovering palm oil alternatives, and re-purposing waste water and plastic, to innovators working on the next-generation of energy storage, battled in the Regional Finals of the Global Challenge held in Singapore.
The runners up were NDR Technologies from Singapore, which develops surgical robotics to assist surgeons during minimally invasive surgery and Biteback from Indonesia, which processes insect to create healthier and more sustainable alternative to palm oil.
Lifespans, as the champion in the region, will contest in the Global Health track finals of the Global Summit held in March 2019 in Paris. The Global Challenge this year saw some 4500 applications from 120 countries.
Lifespans received funding support from TSSSU @HKU (Technology Start-Up Support Scheme for Universities) under HKU's Technology Transfer Office and leveraged on this to raise sizeable private investment for the commercialisation of their technology and the development of the company.
About Hello Tomorrow Singapore
Hello Tomorrow Singapore is the regional (Southeast Asia and Hong Kong) chapter of Hello Tomorrow, started in 2011 by PhD students who were struggling to find support as they sought to adapt their research toward real-world commercial uses.
The organisation has since grown tremendously, with over 20,000 active participants and 11 local hubs across the globe. It is a global non-profit with a mission to unlock the potential of deep technologies to solve the world's toughest challenges, by highlighting, empowering and connecting the most promising deep-tech entrepreneurs globally with the right enablers
About Lifespans Limited (“Lifespans”)
Lifespans is an HKU medical devices start-up which was co-founded by Dr Sloan Kulper, HKU PhD & MIT graduate, Dr Erica Ueda, MIT engineer, Professor William Lu, Professor Frankie Leung, and Dr Christian Fang of Department of Orthopaedics & Traumatology.
Lifespans has developed three innovative implants that are shown in laboratory conditions to provide superior performance for repairing fractures in the elderly: the Lifespans Soft Hip, Soft Shoulder, and Soft Spine. It is presently completing the final safety and efficacy testing required to bring these three innovative orthopaedic devices through the regulatory approval processes in the US and EU, followed by Asian countries, with patents filed in the US, EU, and China. The company anticipates receiving its first approvals for sale to hospitals through its distributor partners starting Q2 2019. Lifespans https://www.lifespans.net/products/.
For the online press release and photos, please visit: https://www.hku.hk/press/news_detail_18915.html
Entrepreneurs in Action – How to Put Everything Together and Get it Started, with Limited Resources
30 Apr 2014
Back to News & Successful Stories
Students seize the opportunity to explore entrepreneurship via internship@CoCoon STEP
25 Feb 2015
Get the latest technology and news from us
If you do not wish to receive emails from us in the future, you can send an unsubscribe request to us by email to firstname.lastname@example.org.